1-5 of 5
Gary Hudes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Increase in Cholesterol Predicts Survival Advantage in Renal Cell Carcinoma Patients Treated with Temsirolimus

Free
Chee Khoon Lee, Ian C. Marschner, R. John Simes, Merryn Voysey, Brian Egleston, Gary Hudes, Paul de Souza
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (11): 3188–3196.
https://doi.org/10.1158/1078-0432.CCR-11-3137
Published: 31 May 2012
View articletitled, Increase in Cholesterol Predicts Survival Advantage in Renal Cell Carcinoma Patients Treated with Temsirolimus
Open the PDF for Increase in Cholesterol Predicts Survival Advantage in Renal Cell Carcinoma Patients Treated with Temsirolimus in another window
Includes: Supplementary data
Journal Articles

Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer

Free
Evan Y. Yu, George Wilding, Edwin Posadas, Mitchell Gross, Stephane Culine, Christophe Massard, Michael J. Morris, Gary Hudes, Fabio Calabrò, Shinta Cheng, Géralyn C. Trudel, Prashni Paliwal, Cora N. Sternberg
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7421–7428.
https://doi.org/10.1158/1078-0432.CCR-09-1691
Published: 30 November 2009
View articletitled, Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
Open the PDF for Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer in another window
Journal Articles

New Paradigm in Dose-Finding Trials: Patient-Specific Dosing and Beyond Phase I

Free
André Rogatko, James S. Babb, Mourad Tighiouart, Fadlo R. Khuri, Gary Hudes
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (15): 5342–5346.
https://doi.org/10.1158/1078-0432.CCR-05-0458
Published: 01 August 2005
View articletitled, New Paradigm in Dose-Finding Trials: Patient-Specific Dosing and Beyond Phase I
Open the PDF for New Paradigm in Dose-Finding Trials: Patient-Specific Dosing and Beyond Phase I in another window
Journal Articles

Transcriptional Profiles in Peripheral Blood Mononuclear Cells Prognostic of Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma

Free
Michael E. Burczynski, Natalie C. Twine, Gary Dukart, Bonnie Marshall, Manuel Hidalgo, Walter M. Stadler, Theodore Logan, Janice Dutcher, Gary Hudes, William L. Trepicchio, Andrew Strahs, Fred Immermann, Donna K. Slonim, Andrew J. Dorner
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (3): 1181–1189.
https://doi.org/10.1158/1078-0432.1181.11.3
Published: 11 February 2005
View articletitled, Transcriptional Profiles in Peripheral Blood Mononuclear Cells Prognostic of Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma
Open the PDF for Transcriptional Profiles in Peripheral Blood Mononuclear Cells Prognostic of Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Phase II Study of Dolastatin-10 in Patients with Hormone-refractory Metastatic Prostate Adenocarcinoma

Free
Uika Vaishampayan, Michael Glode, Wei Du, Andrew Kraft, Gary Hudes, Jeremy Wright, Maha Hussain
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (11): 4205–4208.
Published: 01 November 2000
View articletitled, Phase II Study of Dolastatin-10 in Patients with Hormone-refractory Metastatic Prostate Adenocarcinoma
Open the PDF for Phase II Study of Dolastatin-10 in Patients with Hormone-refractory Metastatic Prostate Adenocarcinoma in another window